I've had investigations of my lab because people didn't like what I had to say. And when you have investigations and you're doing research, you're shut down for a while. You have to start all over again. So that's one area where I paid a high price.

Take crack cocaine. Particularly in the early days of the policy, ninety percent of the people being arrested were black, even though they didn't use the drug at higher rates and even though their numbers in the general population are so low. How could that be? The thing is, you place all your resources in communities of color. And if you do that, you're going to arrest black people.

People rarely die from heroin alone, it's the combination that's deadly. Maybe we should blast that out as a public health education message. That way at least we're keeping people safe.

I don't want to be on the bandwagon of dogging any president or anybody in positions where they have all these different constituencies.

If we want to think about racism and how it might play out in drug policy, we have to think about the trial of George Zimmerman. We think about the prosecution, when they said "race is not a factor." It's so dishonest.

Our ability to study the brain has been limited because of our tools and our tools have only allowed us to look at one neurotransmitter and we haven't looked so much into co-localization and co-release of transmitters. Our thinking is hampered by our tools.

I have three boys. And I wanted to make sure it connected with them and then those guys who grew up like me, in environments like me.And then I knew something about science that your New York Times reader would be interested in. So I was thinking about it in multiple ways: I'll connect with the people who grew up like me first, and then the New York Times reader will be interested in the science because it's so good and they want to be "in the know."